Crossmark

Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19

Crossref DOI link: https://doi.org/10.1016/j.endien.2022.02.008

Published Print: 2022-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Carrasco-Sánchez, Francisco Javier

Carretero-Anibarro, Enrique

Gargallo, Manuel Ángel

Gómez-Huelgas, Ricardo

Merino-Torres, Juan Francisco

Orozco-Beltrán, Domingo

Pines Corrales, Pedro José

Ruiz Quintero, Manuel Antonio
License Information

Text and Data Mining valid from 2022-03-01
More Information

This article is maintained by: Elsevier

Article Title: Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2022.02.008

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.endinu.2021.10.003

Content Type: simple-article

Copyright: © 2021 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.